| |
| |
|
| Insider
Information: |
Freeman Kevin D |
| Relationship: |
|
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,969 |
|
|
Indirect Shares
|
93,063 |
|
|
| Direct
Value |
$86,736 |
|
|
|
Indirect Value
|
$310,830 |
|
|
| Total
Shares |
119,032 |
|
|
| Total
Value |
$397,567 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
12
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
7
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -7.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
|
2024-04-22 |
25,969 |
2024-04-22 |
93,063 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2024-04-22 |
4 |
B |
$2.98 |
$7,450 |
D/D |
2,500 |
25,969 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2024-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,063 |
18,063 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2022-10-28 |
4 |
B |
$1.41 |
$14,100 |
I/I |
10,000 |
75,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2022-05-19 |
4 |
B |
$1.33 |
$6,650 |
I/I |
5,000 |
65,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2022-04-18 |
4 |
B |
$1.71 |
$8,550 |
I/I |
5,000 |
60,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2022-01-19 |
4 |
B |
$1.96 |
$9,806 |
I/I |
5,000 |
50,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2022-01-19 |
4/A |
B |
$1.96 |
$9,806 |
I/I |
5,000 |
55,000 |
0.01 |
- |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2021-12-15 |
4/A |
B |
$2.28 |
$11,400 |
I/I |
5,000 |
50,000 |
0.01 |
- |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2021-12-06 |
4 |
B |
$2.34 |
$11,700 |
I/I |
5,000 |
45,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2021-12-06 |
4 |
B |
$2.28 |
$11,400 |
I/I |
5,000 |
50,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2021-10-21 |
4 |
B |
$3.19 |
$6,380 |
I/I |
2,000 |
38,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2021-10-19 |
4 |
B |
$3.37 |
$10,107 |
I/I |
3,000 |
36,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
|
• • – |
2021-09-23 |
4 |
B |
$3.88 |
$11,631 |
I/I |
3,000 |
33,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2020-09-04 |
4 |
B |
$2.57 |
$12,848 |
I/I |
5,000 |
25,000 |
2.1 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2020-03-19 |
4 |
B |
$1.64 |
$9,844 |
I/I |
6,000 |
20,000 |
2.1 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-11-15 |
4 |
B |
$3.36 |
$10,076 |
I/I |
3,000 |
14,000 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-09-06 |
4 |
B |
$3.71 |
$4,786 |
I/I |
1,290 |
11,000 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-05-31 |
4 |
B |
$4.28 |
$6,103 |
D/D |
1,426 |
23,469 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-05-31 |
4 |
B |
$4.28 |
$32,999 |
I/I |
7,710 |
9,710 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-04-05 |
4 |
B |
$4.73 |
$2,365 |
I/I |
500 |
2,000 |
2.02 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-08 |
4 |
B |
$4.29 |
$6,428 |
I/I |
1,500 |
1,500 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-02-01 |
4 |
B |
$4.10 |
$8,191 |
I/I |
2,000 |
16,000 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2017-12-07 |
4 |
B |
$1.63 |
$13,005 |
I/I |
8,000 |
8,000 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2017-12-07 |
4 |
B |
$1.64 |
$657 |
D/D |
400 |
28,043 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-06-01 |
4 |
B |
$2.70 |
$5,624 |
I/I |
2,083 |
2,083 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
